The new generation of obesity medications are inducing greater weight loss than any prior pharmacotherapy. There is discussion now about how to support fat loss while protecting lean mass.“Lean mass ...

Objectives To determine whether the use of incretin based drugs, compared with sulfonylureas, is associated with an increased risk of acute pancreatitis. Design Population based cohort study. Setting ...

Dublin, April 10, 2025 (GLOBE NEWSWIRE) -- The "Incretin-based Drugs Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Among incretin-based drugs for managing ...

We aimed to investigate whether the reduced incretin effect observed in patients with type 2 diabetes is a primary event in the pathogenesis of type 2 diabetes or a consequence of the diabetic state.

The US Food and Drug Administration (FDA) agrees with the European Medicines Agency (EMA) that available data do not confirm recent concerns over an increased risk for pancreatic side effects with ...

Maturity-onset diabetes of the young (MODY), also known as monogenic diabetes mellitus, is a group of hereditary forms of nonautoimmune diabetes mellitus characterized by late-onset in early adulthood ...

Investing in pharmaceutical companies with diversified revenue bases and strong R&D pipelines could be a lucrative strategy.

Septerna's partnership with Novo Nordisk is a strong endorsement, but the $195m upfront is modest (by Big Pharma standards) and milestone payments are not guaranteed. The company’s innovative GPCR ...

Report Ocean has released a market research report on the Incretin-Based Drugs industry, covering 150+ countries and analyzing over 1,00000 published and forthcoming reports per year. The report, ...

A new international, multicenter study has found that incretin-based drugs, used to treat type 2 diabetes, are not associated with an increased risk of pancreatic cancer. A new international, ...